Johnson & Johnson and AstraZeneca Are Studying Whether Modifying Their COVID-19 Vaccines Can Reduce Or Eliminate The Risk Of Rare Blood Clots

Daily Mail ^ | 07/13/21 | Mark Kekatos

[Enlightened1]

• Johnson & Johnson and AstraZeneca-University of Oxford have begun studying whether their COVID-19 vaccines can be modified
• Both shots have been linked to a risk of blood clots along with a low platelet-count condition known as thrombocytopenia
• Scientists hope to identify the causes behind the blood clots and maybe re-engineer the shots by next year
• In the U.S., J&J's vaccine has been linked to 0.3 cases of rare blood clots per 100,000 doses and AstraZeneca's jab linked to 1-2 cases per 100,000
• It comes one day after it was revealed the FDA is adding a new warning to the label of J&J's vaccine due the risk of a rare autoimmune disorder

Johnson & Johnson, AstraZeneca and the University of Oxford have begun studying whether or not modifying their COVID-19 vaccines can reduce or eliminate the risk of rare, deadly blood clots.

First reported by The Wall Street Journal, sources say scientists are working to  identify the causes behind the blood clots and potentially re-engineer the shots to be distributed by next year.

Both the J&J and AstraZeneca vaccines have been linked to clots along with a low platelet-count condition known as thrombocytopenia, which researchers have dubbed vaccine-induced immune thrombotic thrombocytopenia (VITT).       

A J&J spokesman told The Journal that the New Jersey-based company supports 'continued research and analysis as we work with medical experts and global health authorities' but did not answer specific questions about the early-stage research.

An AstraZeneca spokesperson elaborated and said the firm is 'actively working with the regulators and scientific community to understand these extremely rare blood-clotting events, including information to drive early diagnosis and intervention, and appropriate treatment.'

[butlerweave]

Experimenting on Experimental

[SkyDancer]

Well gee, how nice of them.

[Enlightened1]

Don’t you love how they say “rare”.

If it’s rare, then why are they are trying to change it?

[Enlightened1]

In the meantime they will keep pushing it.

[SeekAndFind]

RE: Johnson & Johnson and AstraZeneca-University of Oxford have begun studying whether their COVID-19 vaccines can be modified

Tens of millions of shots already given and now they tell us they need to study their effects some more.

What does this make these people who have taken the shots?

[P-Marlowe]

It was “rare” until these vaccines were distributed.

Now it’s becoming common.

[Billthedrill]

Don’t you love how they say “rare”.

Yeah, I was wondering about that. Apparently it's rare blood that's the problem. I hope I don't have rare blood.

[SkyDancer]

Yep and you’re anti-American and unpatriotic if you don’t take the shot(s).

[Captain Walker]

These statements seem to become an exercise in the number of times the writer can include the word, “rare” in a single sentence.

[eyedigress]

potentially re-engineer the shots to be distributed by next year.

FAIL!

[moehoward]

I suppose they could just offer injectees a complimentary supply of XARELTO®. The stuff is EXPENSIVE!!

[Enlightened1]

Haha!

I’m am unpatriotic if I don’t want to be a guinea pig with an experimental mRNA gene therapy.

[Enlightened1]

Exactly!

[Pollard]

How about they just admit the obvious. Due to the time it takes to safely test a vaccine, 7-10 years, they never have and never will be able to create a coronavirus vaccine because by the time they were done with the vaccine, the virus would have mutated dozens of times and also probably just weaken and join the rest of the common colds.

[V_TWIN]

These “rare” side effects are apparently not so rare

[arthurus]

Rare Blood Clots is the woke name of a not terribly scarce phenomenon. If it were to develop that 90% of injectees develop the Rare Blood Clots, that would not change “Rare” as it is no longer an adjective but part of the name of the syndrome.

[aMorePerfectUnion]

Why would they spend money to fix this??

Paid Trolls here told me it is rare and no problem!

[fr_freak]

Johnson & Johnson and AstraZeneca Are Studying Whether Modifying Their COVID-19 Vaccines Can Reduce Or Eliminate The Risk Of Rare Blood Clots

After that, perhaps they'll look into reducing the number of run-of-the-mill blood clots. Or perhaps not.

[Bell Bouy II]

How about a drug firm starting from scratch on something new
Since the start its been these 3 prototypes and no mention of anything else.

Not getting it